Ujjivan Financial Services Ltd IPO Message Board (Page 13)

Sudip Bandopadhyay, Market Expert told CNBC-TV18, "For Ujjivan Financial Services , the listing was good but the stock has corrected quite a bit.

Obviously, the first day profit taken by the high-net worth individuals (HNIs) who have leveraged applications, so the price has come down and at current prices which is about 10 percent premium to the issue price, I think it is a good buy." "If you compare it with
Equitas Holdings or other listed microfinance company like SKS Microfinance

I think they are very well positioned. On the parameters which are comparable including profit and the net interest, I think they rank very well. Based on the peer comparison, Ujjivan is a buy at current level,"

he said. " Thyrocare Technologies is an excellent company. They have done well; the listing was a great historical listing. The subscription was great but valuations at this level look a bit reach. So, I will probably wait and not buy Thyrocare at this stage."

Read more at: http://www.moneycontrol.com/news/stocks-views/buy-ujjivan-financial-services-sudip-bandopadhyay_6604741.html?utm_source=ref_article

allotments bi bad aur listing bi bad

ujjivan give death to investors any good come ?

Sare so called expert galat shabit hue...abb listing ke baad kharid bech ne ki recommendation de kar jua khil wa rahe hai

Nowadays gmp is taking 40% cut
Thyrocare gmp 250-40%=150
446+150=596
Ujjivan gmp 50-40%=30
210+30=240

still would say a disappointing listing.

not sure as many retailers would go submit forms and with all these hard work and difficult in allotmet if you get 10 pc gain is pretty disappointing.

even Thyrocare was n''t that great.

i would suggest to take a call after listing for IPO from now on as even good IPO which left a lot for investors haven''t done that well/

Continue to advise Buy or Hold on Ujjivan post listing: Antique

Read more at: http://www.moneycontrol.com/news/ipo-new-listings/continue-to-advise-buy-or-holdujjivan-post-listing-antique_6598001.html?utm_source=ref_article

Ok refresh ourselves for upcoming ipos... any news on mahanagar gas

See Ujjivan at 400 year end 2016

Even by book value ujjivan is trading cheap..its p/bv is just 1.8

when compared with its peers (equitasP/BV-2.4,SKS -7.1) it looks cheap...Ujjivan book value is 128

Darshan Shah ‏@shahdarshan 2h2 hours ago

#Ujjivan mcap is at 43% discount to Equitas and 64% discount to SKS. Trailing P/B of 1.84x vs.P/B of 2.4x of Equitas and 4.5x of SKS.

Hi Eagleeye,Septa,chem cho, Rks

Please share your opinion on HCL.
I am currently holding 60 shares at an average rate of 784.This stock has seen a steady downstream from 840.Please advise if I need to hold or book losses from here .

sir ..

i do not track the stock sorry

Buy at current levels. Do not worry. Its a bluechip stock. The stock is consolidating at present.

Back at 233 ....

Even though all positions are squared up by 15 to 15 .10 from rs 233 is again down to rs 231.10

still selling is seen from ipo holders

PATIENT UJJIVAN BP AT at rs 230. WELL DONE DOCTORS

SAVED THE DAYS AT 230 DOCTORS ADVISED 48 HOURS Monitoring

BP LIKELY TO GONE UP AND DOWN

ujjivan @ 230

now 231

one must buy ujjivan ( p/e 17) .It is trading discount to Equitas (p/e 28 )&sks micro (27)

UJJIVAN RS 237.75 AT 2.38 PM ON 10/5/16

YES

Doctors are trying hard now second myocardial infract at rs 231.5

sir ,

family is distressed

Heavy buying seen in Equitas 145+++

Ujjivan will get same treatment by Bulls.. Buy & Hold...

HEAVY SELLING AT RS 145.4 LOW 137.75

NOW RS 143.9 TIME 2.36

As per graph and logic last 3-4 ipo it''s close in down side I thing in red ya around 220

Ujjivan mooka de raha hi jinhe allotment nahi mila bhar-bhar ke le lo i purches 300 shares at 228.5 target 350/- short term